Radiology Partners Reportedly Eyeing International Expansion

Why It Matters

The deal would give Radiology Partners an immediate foothold in the Australian market, diversifying its revenue base and accelerating the global consolidation of radiology services.

Key Takeaways

• RP eyes acquisition of I‑MED, 240+ Australian clinics
• I‑MED posted ~AU$176 M (~US$116 M) adjusted earnings last year
• RP previously bid for Everlight Radiology, showing market appetite
• Permira may sell I‑MED or pursue IPO amid Asia‑Pacific retreat
• Bank of America and Jefferies advising RP and I‑MED respectively

Pulse Analysis

The radiology sector has entered a phase of rapid consolidation, driven by the need for scale, technology integration, and geographic diversification. Radiology Partners, which commands a dominant position in the U.S. imaging market, has been actively seeking growth beyond domestic borders. By targeting I‑MED, RP would instantly add a network of more than 240 clinics across Australia, a market that has shown steady demand for advanced imaging and teleradiology services. This strategic push reflects a broader industry trend where large providers acquire regional players to broaden service portfolios and leverage economies of scale.

I‑MED’s recent expansion into the United States, highlighted by its acquisition of San Diego‑based StatRad, demonstrates its ambition to become a trans‑pacific imaging powerhouse. Generating approximately AU$176 million in adjusted earnings—equivalent to about US$116 million—the Australian group offers a profitable platform with robust technology infrastructure. Private‑equity owner Permira, facing a strategic pull‑back from the Asia‑Pacific region, is evaluating a sale or an initial public offering to unlock value. An IPO could provide capital for further expansion, while a sale to RP would deliver an immediate exit and align with Permira’s desire for a credible alternative amid uncertain market conditions.

If the transaction proceeds, RP would gain a ready‑made entry into a market with high per‑capita imaging utilization, complementing its existing teleradiology capabilities and strengthening its competitive edge against other global players. The involvement of major advisors—Bank of America for RP and Jefferies for I‑MED—underscores the deal’s financial significance. For investors, the acquisition could signal accelerated revenue growth and a more diversified earnings profile, while also highlighting the ongoing consolidation wave that is reshaping the global radiology landscape.